To translate our findings to MS, we isolated CD11b+ monocytes from peripheral blood mononuclear cells (PBMC) taken from MS patients, at different stages of the disease, including CIS, RRMS and SPMS. This evidence concerns the gene ITGAM and in situ carcinoma.